Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vincent Medical HoldingsHKSE:01612 +1.43%49 ROA % is 9.35% as of Dec. 2025, which is 34% above its 10-year median of 6.97. GuruFocus rates HKSE:01612 with a GF Score™ of 49/100 and a GF Value™ of HK$0.58 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Vincent Medical Holdings ranks better than 86.78% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Vincent Medical Holdings's annualizedNet Income for the quarter that ended in Dec. 2025 was HK$105.5 Mil.
Vincent Medical Holdings's average Total Assets over the quarter that ended in Dec. 2025 was HK$1,127.7 Mil. Therefore, Vincent Medical Holdings's annualized ROA % for the quarter that ended in Dec. 2025 was 9.35%.
The historical rank and industry rank for Vincent Medical Holdings's ROA % or its related term are showing as below:
HKSE:01612'
s ROA % Range Over the Past 10 Years
Min: -2.21 Med: 6.97 Max: 28.59
Current: 9.86
During the past 13 years, Vincent Medical Holdings's highest ROA % was 28.59%. The lowest was -2.21%. And the median was 6.97%.
HKSE:01612's ROA % is ranked better than 86.78% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: 0.5
vs HKSE:01612: 9.86
Vincent Medical Holdings (HKSE:01612) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Vincent Medical Holdings's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vincent Medical Holdings ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vincent Medical Holdings's ROA % distribution charts can be found below:
* The bar in red indicates where Vincent Medical Holdings's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.
ROA % is displayed in the 30-year financial page.
Vincent Medical Holdings (HKSE:01612) has a ROA % of 9.35% as of Dec. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Vincent Medical Holdings and its competitors. This is 34% above median its historical median of 6.97. According to the industry distribution chart, Vincent Medical Holdings ranks #113 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 13.2%.
Is Vincent Medical Holdings' ROA % too high?
Vincent Medical Holdings' current ROA % of 9.35% is 34% above median its 10-year median of 6.97. The Medical Devices & Instruments industry median ROA % is 0.50. Vincent Medical Holdings' value of 9.35% is 1770% above this industry median. Based on the distribution chart, Vincent Medical Holdings ranks #113 out of 855 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Vincent Medical Holdings has a GF Score™ of 49/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vincent Medical Holdings' ROA % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Vincent Medical Holdings ranks #113 out of 855 companies for ROA %. This places Vincent Medical Holdings in the top 13% of its industry — outperforming the majority of peers. The industry median ROA % is 0.50. Vincent Medical Holdings' value of 9.35% is 1770% above this benchmark. While the company's 10-year median is 6.97 vs. the industry median of 0.50, Vincent Medical Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.50, based on 855 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vincent Medical Holdings's current ROA % of 9.35% is 1770% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Vincent Medical Holdings and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vincent Medical Holdings's current ROA % is 9.35%, which is 34% above median its own 10-year median of 6.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vincent Medical Holdings stock overvalued right now?
Based on GuruFocus' analysis, Vincent Medical Holdings (HKSE:01612) is currently considered Modestly Overvalued. The stock's GF Value™ is HK$0.58, compared to a current price of HK$0.71 — trading 22.4% above its estimated fair value. The current ROA % is 9.35%, which is 34% above median its 10-year median of 6.97 and 1770% above the Medical Devices & Instruments industry median of 0.50. Vincent Medical Holdings' overall GF Score™ is 49/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Vincent Medical Holdings (HKSE:01612), the current ROA % is 9.35% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vincent Medical Holdings (HKSE:01612) Overvalued in 2026?
Based on GuruFocus' analysis, Vincent Medical Holdings stock appears to be overvalued.
The current stock price of HK$0.71 is trading 22.4% above its estimated GF Value™ of HK$0.58.
GuruFocus considers Vincent Medical Holdings to be Modestly Overvalued.
Key valuation signals for HKSE:01612:
ROA %: 9.35% (34% above median its 10-year median of 6.97)
GF Value™: HK$0.58 vs. price of HK$0.71 (22.4% above fair value)
Industry Position: 1770% above the Medical Devices & Instruments median (#113 of 855)
No single metric tells the full story. See the HKSE:01612 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vincent Medical Holdings Ltd is an investment holding company engaged in the manufacturing and selling of medical devices focusing on imaging disposable products on an OEM basis to one of the world's diagnostic imaging solutions providers. The company operates in two segments: OEM (original equipment manufacturing) and OBM (original brand manufacturing). The OEM segment manufactures products as per the customer's requirements. The OBM segment includes research, development, manufacturing, marketing, and sales of medical devices under the Inspired Medical, and Hand of Hope brands. The geographical segments of the company includes the United States, Spain, the PRC, Japan, Costa Rica, the Netherlands, Germany, and Others. It derives its maximum revenue from Spain.
49GF Score
Get the complete analysis for HKSE:01612
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01612 has been successfully added to your 
